Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore.
Maturitas. 2021 Dec;154:46-54. doi: 10.1016/j.maturitas.2021.09.005. Epub 2021 Sep 17.
Obesity and chronic kidney disease (CKD) are major public health problems worldwide. However, the association between body mass index (BMI) and CKD is inconclusive in Asians. In this meta-analysis, eight population-based studies, from China, India, Russia (Asian), Singapore and South Korea, provided individual-level data (n=50037). CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m. BMI was analyzed both as a continuous variable and in three categories: <25kg/m, normal; 25-29.9kg/m, overweight; and ≥30kg/m, obese. The association between BMI and CKD was evaluated in each study using multivariable logistic regression models and individual estimates were pooled using random-effect meta-analysis to obtain the pooled odds ratio (OR) and 95% confidence interval (CI). Associations were also evaluated in subgroups of age, gender, smoking, diabetes, and hypertension status. Of 50037 adults, 4258 (8.5%) had CKD. 13328 (26.6%) individuals were overweight while 4440 (8.9%) were obese. The prevalence of any CKD ranged from 3.5% to 29.1% across studies. In pooled analysis, both overweight and obesity were associated with increased odds of CKD, with pooled OR (95% CI) of 1.15 (1.03-1.29) and 1.23 (1.06-1.42), respectively. In subgroup analyses, significant associations between BMI and CKD were observed in adult males, non-smokers, and those with diabetes and arterial hypertension (all p<0.05). When evaluated as a continuous variable, BMI was not significantly associated with CKD. If confirmed in longitudinal studies, these results may have clinical implications in risk stratification and preventive measures, given that obesity and CKD are two major chronic diseases with substantial public health burden worldwide.
肥胖和慢性肾脏病(CKD)是全球主要的公共卫生问题。然而,亚洲人群中体重指数(BMI)与 CKD 之间的关系尚无定论。在这项荟萃分析中,来自中国、印度、俄罗斯(亚洲)、新加坡和韩国的八项基于人群的研究提供了个体水平的数据(n=50037)。CKD 的定义为估算肾小球滤过率(eGFR)<60mL/min/1.73m。BMI 既作为连续变量进行分析,也分为三个类别:<25kg/m,正常;25-29.9kg/m,超重;和≥30kg/m,肥胖。使用多变量逻辑回归模型在每项研究中评估 BMI 与 CKD 之间的关系,并使用随机效应荟萃分析汇总个体估计值以获得汇总优势比(OR)和 95%置信区间(CI)。还根据年龄、性别、吸烟、糖尿病和高血压状况的亚组评估了关联。在 50037 名成年人中,有 4258 人(8.5%)患有 CKD。13328 人(26.6%)超重,4440 人(8.9%)肥胖。各项研究中任何 CKD 的患病率范围为 3.5%至 29.1%。在汇总分析中,超重和肥胖均与 CKD 发生的几率增加相关,汇总 OR(95%CI)分别为 1.15(1.03-1.29)和 1.23(1.06-1.42)。在亚组分析中,在成年男性、不吸烟者以及患有糖尿病和动脉高血压的人群中,BMI 与 CKD 之间存在显著关联(均 p<0.05)。当作为连续变量进行评估时,BMI 与 CKD 无显著关联。如果在纵向研究中得到证实,鉴于肥胖和 CKD 是全球范围内具有重大公共卫生负担的两种主要慢性疾病,这些结果可能具有风险分层和预防措施方面的临床意义。